These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10852302)

  • 21. Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
    Parenti D; Murray CW
    Arthritis Rheum; 2001 Jun; 44(6):1470-1; author reply 1473-6. PubMed ID: 11407711
    [No Abstract]   [Full Text] [Related]  

  • 22. Experiences of viscosupplementation for knee osteoarthritis.
    Campbell DG; Angel KR; Dobson PJ; Lewis PL; Tandon S
    Aust Fam Physician; 2004 Oct; 33(10):863-4. PubMed ID: 15532168
    [No Abstract]   [Full Text] [Related]  

  • 23. Synvisc perisynovitis.
    Zardawi IM; Chan I
    Pathology; 2001 Nov; 33(4):519-20. PubMed ID: 11827424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H; Burkhardt D; Sambrook P; March L
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis.
    Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
    Ann Rheum Dis; 2005 Jun; 64(6):881-5. PubMed ID: 15564311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
    Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
    J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
    Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
    Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
    Zietz PM; Selesnick H
    Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute local reaction after intra-articular injection of HYALAN G-F 20 (Synvisc) for treatment of gonarthrosis onset].
    Oswald A; Gächter A
    Praxis (Bern 1994); 2000 Nov; 89(46):1929-31. PubMed ID: 11111412
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis.
    Karatay S; Kiziltunc A; Yildirim K; Karanfil RC; Senel K
    Ann Clin Lab Sci; 2004; 34(3):330-5. PubMed ID: 15487709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis.
    Novaes AC; Schaiquevich P; Nasswetter G;
    Int J Clin Pharmacol Res; 2005; 25(1):1-7. PubMed ID: 15864872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viscosupplementation treatments.
    Waddell DD
    J South Orthop Assoc; 2000; 9(1):79. PubMed ID: 12132815
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of two different viscosupplements in knee osteoarthritis -- a pilot study.
    Bayramoğlu M; Karataş M; Cetin N; Akman N; Sözay S; Dilek A
    Clin Rheumatol; 2003 May; 22(2):118-22. PubMed ID: 12740676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study.
    Bunyaratavej N; Chan KM; Subramanian N
    J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S576-81. PubMed ID: 11853284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-articular injections for osteoarthritis of the knee.
    Med Lett Drugs Ther; 2006 Mar; 48(1231):25-7. PubMed ID: 16554699
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter to the Editor: Reply to the letter by Max I. Hamburger.
    Raynauld JP; Goldsmith CH; Torrance GW;
    Osteoarthritis Cartilage; 2005 Nov; 13(11):1037-8; author reply 1039-40. PubMed ID: 16169753
    [No Abstract]   [Full Text] [Related]  

  • 37. Knee osteoarthritis: should your patient opt for hyaluronic acid injection?
    Medina JM; Thomas A; Denegar CR
    J Fam Pract; 2006 Aug; 55(8):669-75. PubMed ID: 16882439
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Karlsson et al. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study.
    Magilavy D; Polisson R; Parenti D
    Rheumatology (Oxford); 2003 Oct; 42(10):1262; author reply 1262-3. PubMed ID: 14508044
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
    Milas M; Rinaudo M; Roure I; Al-Assaf S; Phillips GO; Williams PA
    Biopolymers; 2001 Oct; 59(4):191-204. PubMed ID: 11473346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.